ArticleJournal of the American Society of Nephrology : JASN2025
Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies.
Philipp Gauckler et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this papercites it